(135 days)
Not Found
No
The device description and performance studies focus on laser therapy and electrical safety, with no mention of AI or ML algorithms for analysis, treatment planning, or any other function.
Yes
The 'Intended Use / Indications for Use' section explicitly states, "The Theradome Laser Helmet LH80 PRO is a prescription use therapeutic device indicated to promote hair growth in females, with androgenic alopedia." The 'Intended User / Care Setting' also confirms it is a "prescription use therapeutic device".
No
The device is described as a "therapeutic device" intended to treat androgenic alopecia by promoting hair growth, rather than diagnosing a condition.
No
The device description explicitly states it is a "low level laser therapy (LLT) device" and mentions "lasers are contained inside a lightweight, one-size fits all helmet," indicating it is a hardware device with integrated lasers.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The Theradome Laser Helmet LH80 PRO is a therapeutic device that uses low-level laser therapy applied externally to the scalp to promote hair growth. It does not analyze any samples taken from the body.
- Intended Use: The intended use clearly states it's for treating androgenic alopecia by promoting hair growth, not for diagnosing or detecting a condition through in vitro analysis.
The device description and intended use clearly indicate it's a therapeutic device for external application, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The Theradome Laser Helmet LH80 PRO is intended to treat androgenic alopecia by promoting hair growth.
The Theradome Laser Helmet LH80 PRO is a prescription use therapeutic device indicated to promote hair growth in females, with androgenic alopedia, having Ludwig and Savin Hair Loss Scale classification I-II and Fitzpatrick Skin-Types I to IV.
Product codes
OAP, NHN
Device Description
The Theradome Laser Helmet LH80 PRO is a low level laser therapy (LLT) device used to promote hair growth via photobiostimulation. The lasers are contained inside a lightweight, one-size fits all helmet. The LH80 PRO utilizes laser diodes in the heimet to deliver laser stimulation to the entire scalp for hands-free operation during treatment. The device is one-button operated, and has an audible timer that automatically turns the lasers off after the 20 minute treatment completes.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
scalp
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Nonclinical Testing: Performance testing was conducted to confirm compliance to design specifications; all functions were verified to operate as designed.
Testing to IEC 60601-1 and 60601-1-2 confirm the device's safety and electrical compatibility. Testing to IEC 60825-1 certifies the laser system to classification 3R, same as predicate device.
Key Metrics
Not Found
Predicate Device(s)
RF Midwest LLC MEP-90 Hair Growth Stimulation System (K091496)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 890.5500 Infrared lamp.
(a)
Identification. An infrared lamp is a device intended for medical purposes that emits energy at infrared frequencies (approximately 700 nanometers to 50,000 nanometers) to provide topical heating.(b)
Classification. Class II (special controls). The device, when it is an infrared therapeutic heating lamp, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 890.9.
0
K1/3097
page ① of
Section 5
510(k) Summary
This 510k summary of safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92
Manufacturer
Theradome Inc. Address: 4900 Hopyard Road, Suite 100 Pleasanton, CA 94588 Telephone: 510-714-0525 Fax: 925-374-1202
Official Correspondents
Mr. Larry Petersen Requiatory Consultant to Theradome 1001 Bear Island Road, Suite 139 Summerville, SC 29483 Telephone: 303-489-2500 Fax: 925-374-1202 Email: LarryPetersen7@gmail.com
Ms. Parul Chansoria Telephone: 650-796-5878 Email: parul.bme@gmail.com
Date of Submission: October 3, 2011
Device Name and Classification
Product Name:
Product Code: Requiation Number: Panel: Class: Substantial Equivalence claimed to: LH80 PRO Laser Helmet Infrared lamp per 21 CFR 890.5500 OAP 21 CFR 890.5500 General and Plastic Surgery II RF Midwest LLC MEP-90 Hair Growth Stimulation System (K091496)
Device Description
The Theradome Laser Helmet LH80 PRO is a low level laser therapy (LLT) device used to promote hair growth via photobiostimulation. The lasers are contained inside a lightweight, one-size fits all helmet. The LH80 PRO utilizes laser diodes in the heimet to deliver laser stimulation to the entire scalp for hands-free operation during treatment. The device is one-button operated, and has an audible timer that automatically turns the lasers off after the 20 minute treatment completes.
Theradome
1
ı heradome Inc. Laser Helmet LH80 PRO
K113097 Pa
Page (2) of (2)
Intended use
The Theradome Laser Helmet LH80 PRO is intended to treat androgenic alopecia by promoting hair growth.
Indications for Use
The Theradome Laser Helmet LH80 PRO is a prescription use therapeutic device indicated to promote hair growth in females, with androgenic alopedia, having Ludwig and Savin Hair Loss Scale classification I-II and Fitzpatrick Skin-Types I to IV.
Technological Characteristics
The LH80 PRO delivers visible red low-level laser radiant energy to the LH80 PRO utilizes laser diodes to deliver laser stimulation to the entire scalp for hands-free operation during treatment.
Performance Characteristics
Testing to IEC 60601-1 and 60601-1-2 confirm the device's safety and electrical compatibility. Testing to IEC 60825-1 certifies the laser system to classification 3R, same as predicate device.
Nonclinical Testing
Performance testing was conducted to confirm compliance to design specifications; all functions were verified to operate as designed.
Substantial Equivalence
Theradome wishes to use the following device as predicate:
RF Midwest LLC MEP-90 Hair Growth Stimulation System (K091496)
The LH80 PRO has the same intended use as the predicate device: treat androgenic alopedia hair growth.
The LH80 PRO has the same indications for use as the predicate device: prescription use device to promote hair growth in females, with androgenic alopedia; having Ludwig and Savin Hair Loss Scale classification I-II and Fitzpatrick Skin-Types I to IV.
The MEP-90 and the LH80 PRO both deliver treatment to the entire scalp for hands-free operation during treatment, and have the same treatment schedule.
For those reasons, the Theradome Laser Helmet LH80 PRO satisfies FDA's substantial equivalence with respect to both intended use and technological characteristics.
2
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a stylized eagle or bird symbol, with three curved lines representing the wings and body. The logo is surrounded by a circular border with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" written around it.
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
Theradome. Inc. % Mr. Larry Petersen Regulatory Affairs 1001 Bear Island Road, Suite 136 Summerville, South Carolina 29483
MAR - 2 2012
Re: K113097
Trade/Device Name: Theradome Laser Helmet LH80 PRO Regulation Number: 21 CFR 890.5500 Regulation Name: Infrared lamp Regulatory Class: II Product Code: NHN, OAP Dated: February 12, 2012 Received: March 1, 2012
Dear Mr. Petersen:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21
3
Page 2 - Mr. Larry Petersen
CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely vours.
Erind Keith
- Mark N. Melkerson Director Division of Surgical, Orthopedic and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Section 4 Indications for Use Statement
Device Name: Theradome Laser Helmet LH80 PRO
Indications for Use:
The Theradome Laser Helmet LH80 PRO is a prescription use therapeutic device indicated to promote hair growth in females, with androgenic alopecia, having Ludwig and Savin Hair Loss Scale classification I-II and Fitzpatrick Skin-Types I to IV.
Prescription Use __ X_ (Part 21 CFR 801 Subpart D) .
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Neil R.P. Ogden Surmkn
(Division Sign-Off) Division of Surgical, Orthopedic, and Restorative Devices
510(k) Number K113097
Theradome